Midostaurin in MRD (Minimal Residual Disease) Positive Acute Myeloid Leukemia After Allogeneic Stem Cell Transplantation
Condition: Acute Myeloid Leukemia, Adult Intervention: Drug: Midostaurin Sponsors: Sebastian Scholl, PD Dr. med.; Ludwig-Maximilians - University of Munich Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Acute Leukemia | Acute Myeloid Leukemia | Leukemia | Research | Stem Cell Therapy | Stem Cells | Transplants